Patent · US Active

Treatment of carpal tunnel syndrome by injection of the flexor retinaculum

US9901688B2 · kind B2 · utility

1Cited by
36References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2014
Grant dateFeb 27, 2018
Priority date
Expiry dateMay 2, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/083
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.